Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6017381 | Experimental Neurology | 2015 | 38 Pages |
Abstract
Although human cell therapy studies report improved behavioral outcomes in the majority of preclinical literature, the methods are too heterogeneous to facilitate direct comparisons and bias was detected. Replication and standardization are needed to identify procedural variables to yield the best results. We encourage the use of quality criteria and rigor for future studies of human cell therapy in animal models of TBI.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Janessa Chang, Michael Phelan, Brian J. Cummings,